Selection of RNAi-based inhibitors for anti-HIV gene therapy

doi:10.5501/wjv.v1.i3.79

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 1, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4307)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-1) series.

Item

Count

PDF

461

HTML

3446

Figures (1-7)

232

Tables (1-1)

168

Sum=4307

Jun 12, 2012 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Guidelines For Basic Science

World J Virol. Jun 12, 2012; 1(3): 79-90
Published online Jun 12, 2012. doi: 10.5501/wjv.v1.i3.79

Full Size Figure Download Figure

Figure 1 Selection of short hairpin RNAs against human immunodeficiency virus type 1. Scheme of the 10 steps used for the selection of the best shRNA inhibitors for development of an antiviral RNA interference (RNAi) gene therapy. HIV-1: Human immunodeficiency virus type 1.

Citation: Knoepfel SA, Centlivre M, Liu YP, Boutimah F, Berkhout B. Selection of RNAi-based inhibitors for anti-HIV gene therapy. World J Virol 2012; 1(3): 79-90
URL: https://www.wjgnet.com/2220-3249/full/v1/i3/79.htm
DOI: https://dx.doi.org/10.5501/wjv.v1.i3.79